Chemically synthesized human survivin does not inhibit caspase-3

Protein Science

Volumn 17, Issue 9, 2008, Pages 1624-1629

  Li, Changqing ^a   Wu, Zhibin ^a   Liu, Min ^a   Pazgier, Marzena ^a   Lu, Wuyuan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Enzyme inhibitors; Enzymes; Methods of protein and peptide synthesis; Synthesis of peptides and proteins

Indexed keywords

AMINO ACID; CASPASE 3; RECOMBINANT PROTEIN; RECOMBINANT X LINKED INHIBITOR OF APOPTOSIS; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); ENZYME INHIBITION; GEL PERMEATION CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; APOPTOSIS; BUFFERS; CASPASE 3; CELL DEATH; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SOLUTIONS; WATER; ZINC;

EID: 50049122989     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.036145.108     Document Type: Article

References (27)

1. Altieri, D.C. 2003. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3: 46-54.
2. Ambrosini, G., Adida, C., and Altieri, D.C. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3: 917-921.
3. Bang, D. and Kent, S.B. 2004. A one-pot total synthesis of crambin. Angew. Chem. Int. Ed. Engl. 43: 2534-2538.
4. Banks, D.P., Plescia, J., Altieri, D.C., Chen, J., Rosenberg, S.H., Zhang, H., and Ng, S.C. 2000. Survivin does not inhibit caspase-3 activity. Blood 96: 4002-4003.
5. Chantalat, L., Skoufias, D.A., Kleman, J.P., Jung, B., Dideberg, O., and Margolis, R.L. 2000. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual α-helical extensions. Mol. Cell 6: 183-189.
6. Conway, E.M., Pollefeyt, S., Cornelissen, J., DeBaere, I., Steiner-Mosonyi, M., Ong, K., Baens, M., Collen, D., and Schuh, A.C. 2000. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood 95: 1435-1442.
7. Cory, S. and Adams, J.M. 2002. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2: 647-656.
8. Dawson, P.E. and Kent, S.B. 2000. Synthesis of native proteins by chemical ligation. Annu. Rev. Biochem. 69: 923-960.
9. Dawson, P.E., Muir, T.W., Clark-Lewis, I., and Kent, S.B. 1994. Synthesis of proteins by native chemical ligation. Science 266: 776-779.
10. Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304.
11. Eckelman, B.P., Salvesen, G.S., and Scott, F.L. 2006. Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Rep. 7: 988-994.
12. Li, X., de Leeuw, E., and Lu, W. 2005. Total chemical synthesis of human psoriasin by native chemical ligation. Biochemistry 44: 14688-14694.
13. Marusawa, H., Matsuzawa, S., Welsh, K., Zou, H., Armstrong, R., Tamm, I., and Reed, J.C. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22: 2729-2740.
14. Muchmore, S.W., Chen, J., Jakob, C., Zakula, D., Matayoshi, E.D., Wu, W., Zhang, H., Li, F., Ng, S.C., and Altieri, D.C. 2000. Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol. Cell 6: 173-182.
15. Pace, C.N., Vajdos, F., Fee, L., Grimsley, G., and Gray, T. 1995. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4: 2411-2423.
16. Salvesen, G.S. and Dixit, V.M. 1997. Caspases: Intracellular signaling by proteolysis. Cell 91: 443-446.
17. Salvesen, G.S. and Duckett, C.S. 2002. IAP proteins: Blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3: 401-410.
18. Schnolzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S.B. 1992. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int. J. Pept. Protein Res. 40: 180-193.
19. Shi, Y. 2002. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9: 459-470.
20. Shin, S., Sung, B.J., Cho, Y.S., Kim, H.J., Ha, N.C., Hwang, J.I., Chung, C.W., Jung, Y.K., and Oh, B.H. 2001. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40: 1117-1123.
21. Song, Z., Yao, X., and Wu, M. 2003. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during Taxol-induced apoptosis. J. Biol. Chem. 278: 23130-23140.
22. Strasser, A., O'Connor, L., and Dixit, V.M. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69: 217-245.
23. Sun, C., Nettesheim, D., Liu, Z., and Olejniczak, E.T. 2005. Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 44: 11-17.
24. Suzuki, A., Ito, T., Kawano, H., Hayashida, M., Hayasaki, Y., Tsutomi, Y., Akahane, K., Nakano, T., Miura, M., and Shiraki, K. 2000. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19: 1346-1353.
25. Tamm, I., Wang, Y., Sausville, E., Scudiero, D.A., Vigna, N., Oltersdorf, T., and Reed, J.C. 1998. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58: 5315-5320.
26. Thornberry, N.A. and Lazebnik, Y. 1998. Caspases: Enemies within. Science 281: 1312-1316.
27. Verdecia, M.A., Huang, H., Dutil, E., Kaiser, D.A., Hunter, T., and Noel, J.P. 2000. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7: 602-608.